COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Safety, Tolerability and Immunogenicity of Vaccine Candidate MVA-MERS-S

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03615911
Recruitment Status : Completed
First Posted : August 6, 2018
Last Update Posted : October 2, 2019
Philipps University Marburg Medical Center
Ludwig-Maximilians - University of Munich
Charite University, Berlin, Germany
Bernhard Nocht Institute for Tropical Medicine
University of Cologne
Information provided by (Responsible Party):
Marylyn Addo, Universitätsklinikum Hamburg-Eppendorf

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : April 15, 2019
Actual Study Completion Date : May 10, 2019
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 April 28, 2020
May 13, 2020
2 May 28, 2020

Publications automatically indexed to this study by Identifier (NCT Number):